reserpine has been researched along with Catatonia in 43 studies
Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a patient whose periods of periodic catatonia were abolished by thyroid hormone and reserpine." | 7.69 | Thyroid hormone and reserpine abolished periods of periodic catatonia: a case report. ( Kodama, S; Komori, T; Nomaguchi, M; Nomura, J; Takigawa, M, 1997) |
| " The extract at both the doses displayed a significant reduction in postural flexion, moderate decrease in tremor, muscular rigidity and postural immobility scores but do not exhibit significant lowering of hypokinesia score in reserpine induced Parkinsonian model." | 4.12 | Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates. ( Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S, 2022) |
| "We report the case of a patient whose periods of periodic catatonia were abolished by thyroid hormone and reserpine." | 3.69 | Thyroid hormone and reserpine abolished periods of periodic catatonia: a case report. ( Kodama, S; Komori, T; Nomaguchi, M; Nomura, J; Takigawa, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (95.35) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pal Roy, S | 1 |
| Kadiri, SK | 1 |
| Karkar, VV | 1 |
| Rao Konijeti, S | 1 |
| BARUK, H | 3 |
| LAUNAY, J | 1 |
| BERGES, J | 3 |
| BARBIER, A | 2 |
| LECONTE, M | 2 |
| LAUNAY, S | 2 |
| RASHKIS, HA | 1 |
| SMARR, ER | 1 |
| SERGIO, C | 1 |
| ALEMA, G | 1 |
| SMYTH, VO | 1 |
| NOBILE, S | 1 |
| COSSIO, M | 1 |
| DMITRIEV, LI | 1 |
| BILY, J | 2 |
| HACHIYA, H | 1 |
| DERZSI, S | 1 |
| FENYVESI, T | 1 |
| BOISSIER, JR | 1 |
| SIMON, P | 1 |
| THEOBALD, W | 1 |
| BUECH, O | 1 |
| KUNZ, HA | 1 |
| MORPURGO, C | 1 |
| STENGER, EG | 1 |
| WILHELMI, G | 1 |
| GISSEN, LD | 1 |
| GERMANO, G | 1 |
| TOLMASSKAIA, ES | 1 |
| ARSHAVSKII, VV | 1 |
| Lallouette, P | 1 |
| Mordelet-Dambrine, M | 1 |
| Treize, G | 1 |
| N'Guyen, VT | 1 |
| Dubois, AM | 1 |
| Parrot, JL | 1 |
| Komori, T | 1 |
| Nomaguchi, M | 1 |
| Kodama, S | 1 |
| Takigawa, M | 1 |
| Nomura, J | 1 |
| Carchedi, F | 2 |
| Cerbo, R | 2 |
| Accornero, N | 1 |
| Bini, G | 1 |
| Casacchia, M | 3 |
| Meco, G | 1 |
| David, J | 1 |
| Kaul, CL | 1 |
| Grewal, RS | 1 |
| Lisciani, R | 1 |
| Baldini, A | 1 |
| de Feo, G | 1 |
| Silvestrini, B | 1 |
| Poirier, LJ | 3 |
| Péchadre, JC | 1 |
| Larochelle, L | 3 |
| Dankova, J | 1 |
| Boucher, R | 1 |
| Piccione, M | 1 |
| Laguardia, S | 1 |
| Agnoli, A | 1 |
| Aley, KO | 1 |
| Kulkarni, SK | 1 |
| Müller-Calgan, H | 1 |
| Sommer, S | 1 |
| Weil-Malherbe, H | 1 |
| Gessa, GL | 1 |
| Krishna, G | 1 |
| Forn, J | 1 |
| Tagliamonte, A | 1 |
| Brodie, BB | 1 |
| Rogers, KJ | 1 |
| Slater, P | 1 |
| Bédard, P | 2 |
| Sourkes, TL | 1 |
| Parent, A | 1 |
| Brossi, A | 1 |
| Pool, W | 1 |
| Sheppard, H | 2 |
| Burns, JJ | 1 |
| Kaiser, A | 1 |
| Bigler, R | 1 |
| Bartholini, G | 1 |
| Pletscher, A | 1 |
| Takahashi, S | 1 |
| Gjessing, LR | 3 |
| Horst, WD | 1 |
| Pool, WR | 2 |
| Spiegel, HE | 1 |
| Felix, AM | 1 |
| Winter, DP | 1 |
| Wang, SS | 1 |
| Kulesha, ID | 1 |
| Hane, DL | 1 |
| Cesare, LC | 1 |
| Carlini, GR | 1 |
| Carlini, EA | 1 |
| Balzano, E | 1 |
| Naquet, R | 1 |
| Stille, G | 2 |
| Sayers, A | 1 |
1 review available for reserpine and Catatonia
| Article | Year |
|---|---|
The biochemistry of the functional psychoses.
Topics: Acetylcholinesterase; Adenosine Triphosphatases; Animals; Behavior, Animal; Blood Proteins; Catatoni | 1967 |
42 other studies available for reserpine and Catatonia
| Article | Year |
|---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antipar | 2022 |
[A new form of experimental catatonia: experimental catatonia induced by reserpine].
Topics: Antihypertensive Agents; Catalepsy; Catatonia; Reserpine; Secologanin Tryptamine Alkaloids | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
[Combined chlorpromazine-reserpine therapy of a severe hebephrenic-catatonic syndrome of 10 years' duration].
Topics: Catatonia; Chlorpromazine; Reserpine; Schizophrenia; Schizophrenia, Disorganized; Syndrome | 1956 |
Action of reserpine on psychomotricity and experimental catatonia.
Topics: Catatonia; Humans; Movement; Reserpine | 1956 |
Action of reserpine on psychomotricity and experimental catatonia.
Topics: Catatonia; Humans; Movement; Reserpine | 1956 |
Action of reserpine on psychomotricity and experimental catatonia.
Topics: Catatonia; Humans; Movement; Reserpine | 1956 |
Action of reserpine on psychomotricity and experimental catatonia.
Topics: Catatonia; Humans; Movement; Reserpine | 1956 |
Drug and milieu effects with chronic schizophrenics.
Topics: Amobarbital; Catatonia; Methylphenidate; Reserpine; Schizophrenia; Trihexyphenidyl | 1957 |
[Behavior of experimental catatonia induced by bulbocapnine in rats under the action of various drugs. IV. Action of reserpine].
Topics: Alkaloids; Animals; Aporphines; Catatonia; Rats; Reserpine | 1957 |
The use of reserpine in psychiatry.
Topics: Catatonia; Convulsive Therapy; Electroconvulsive Therapy; Humans; Psychiatry; Psychosurgery; Psychot | 1957 |
[Remarke on experimental catatonia induced with reserpine].
Topics: Catatonia; Reserpine | 1957 |
[On the therapeutic mechanism of the effect of reserpine in the catatonic stuporous form of schizophrenia].
Topics: Catatonia; Humans; Reserpine; Schizophrenia | 1963 |
[EFFECT OF VARIOUS PHARMACOLOGICAL AGENTS ON CATALEPTIC SYMPTOMS IN CATATONIC STUPOR].
Topics: Amphetamine; Amphetamines; Catalepsy; Catatonia; Chlorpromazine; Humans; Reserpine; Stupor | 1963 |
[PHARMACOTHERAPY OF SCHIZOPHRENIA. I. PHARMACOTHERAPY WITH IN-PATIENTS OF SHORT-TERM ADMISSION].
Topics: Adolescent; Catatonia; Child; Chlorpromazine; Convulsive Therapy; Electroconvulsive Therapy; Humans; | 1964 |
[APROPOS OF THE PATHOPHYSIOLOGY OF CATATONIC STUPOR].
Topics: Amphetamine; Amphetamines; Catatonia; Chlorpromazine; Pharmacology; Rabbits; Research; Reserpine; St | 1963 |
HIREPINE IN PSYCHIATRY.
Topics: Catatonia; Chlorpromazine; Convulsive Therapy; Dementia; Depression; Electroconvulsive Therapy; Huma | 1964 |
[EXPERIMENTAL EQUIVALENTS OF THE NEUROLOGIC SYNDROME OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Neuro | 1964 |
[COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS WITH TOFRANIL, PERTOFRAN AND INSIDON].
Topics: Acetylcholine; Amphetamine; Amphetamines; Anesthetics; Animals; Antidepressive Agents; Catatonia; Ca | 1964 |
[DYNAMICS OF IMMEDIATE EFFECTIVENESS OF TREATMENT OF SCHIZOPHRENICS. (COMPARATIVE EVALUATION OF VARIOUS THERAPEUTIC METHODS)].
Topics: Catatonia; Chlorpromazine; Convulsive Therapy; Electricity; Electroconvulsive Therapy; Hallucination | 1963 |
[PROTRACTED RESERPINE TREATMENT AND ELECTROSHOCK: CONSIDERATIONS ON THE OPPORTUNITIES AND POSSIBILITIES OF ASSOCIATION].
Topics: Adolescent; Apnea; Biomedical Research; Catatonia; Convulsive Therapy; Depression; Drug Therapy; Ele | 1964 |
[ON THE ELECTROPHYSIOLOGIC ANALYSIS OF THE CENTRAL ACTION OF RESERPINE].
Topics: Arteriosclerosis; Catatonia; Chorea; Drug Therapy; Electroencephalography; Hypertension; Mental Diso | 1964 |
Pharmacological approach of a new isoquinoline derivative (458 L).
Topics: Animals; Catatonia; Guinea Pigs; Histamine Antagonists; Histidine Decarboxylase; Humans; Isoquinolin | 1981 |
Thyroid hormone and reserpine abolished periods of periodic catatonia: a case report.
Topics: Adult; Androsterone; Antipsychotic Agents; Biomarkers; Catatonia; Drug Therapy, Combination; Etiocho | 1997 |
[Experimental syndrome induced by reserpine: changes produced by electroshock and electrosleep].
Topics: Animals; Catatonia; Electronarcosis; Electroshock; Humans; Rats; Reserpine | 1978 |
Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice.
Topics: Animals; Antiparkinson Agents; Ataxia; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Ma | 1979 |
Pharmacological investigations on etoperidone, a new psychotropic agent.
Topics: Analgesics; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Body Temperature; Catato | 1978 |
Stereotaxic lesions and movement disorders in monkeys.
Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; | 1975 |
[Role of serotonin in catatonia induced with haloperidol and reserpine].
Topics: Animals; Brain; Catatonia; Haloperidol; Humans; Male; Rats; Reserpine; Serotonin; Serotonin Antagoni | 1976 |
[Experimental syndrome produced by reserpine. Changes induced by electroshock].
Topics: Animals; Brain; Catatonia; Electroconvulsive Therapy; Humans; Male; Rats; Reserpine | 1975 |
Anticatatonic effect of venoruton.
Topics: Animals; Anticoagulants; Antipsychotic Agents; Catatonia; Female; Haloperidol; Hydroxyethylrutoside; | 1988 |
[Reserpine-parkinsonoid syndrome in the chimpanzee and its treatment with fencamfamin].
Topics: Animals; Antidepressive Agents; Catatonia; Hominidae; Humans; Movement Disorders; Parkinson Disease; | 1968 |
Behavioral and vegetative effects produced by dibutyryl cyclic AMP injected into different areas of the brain.
Topics: Amygdala; Animals; Basal Ganglia; Behavior, Animal; Butyrates; Catatonia; Cats; Caudate Nucleus; Cer | 1970 |
Brain acetylcholine and monoamines during experimental catatonia.
Topics: Acetylcholine; Alkaloids; Amines; Animals; Brain Chemistry; Catatonia; Chlorpromazine; Dopamine; Fem | 1971 |
Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey.
Topics: Animals; Catatonia; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Haplorhini; Human | 1971 |
[Control of motor activity in relation to monoaminergic mechanisms].
Topics: Animals; Brain; Catatonia; Cerebellum; Corpus Striatum; Dopamine; Dopamine Antagonists; Haplorhini; | 1972 |
L-DOPA: chemical modifications and biological evaluation.
Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermi | 1974 |
Studies of periodic catatonia. IV. Longitudinal study of catecholamine metabolism, with and without drugs.
Topics: Body Temperature; Catatonia; Catecholamines; Chromatography, Thin Layer; Disulfiram; Dopamine; Epine | 1972 |
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Blepharoptosis; Brain; | 1973 |
A review of periodic catatonia.
Topics: Age Factors; Animals; Arousal; Basal Metabolism; Body Temperature; Body Weight; Catatonia; Chlorprom | 1974 |
Synthesis and antireserpine activity of peptides of L-dopa.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Blepharoptosis; Catatonia; Dihydroxyphenylalanine; | 1974 |
Influence of histamine on the catatonia induced in mice by tetrabenazine and reserpine.
Topics: Amine Oxidase (Copper-Containing); Animals; Blood Pressure; Capillary Permeability; Catatonia; Drug | 1967 |
[Effect of reserpine on the photosensitive Papio papio: changes in behavior and electroencephalography].
Topics: Age Factors; Animals; Behavior, Animal; Body Temperature Regulation; Catatonia; Electroencephalograp | 1970 |
[Pharmacology of catatonigenic drugs. 2. Elimination of the N. caudatus and the catatonigenic effects of neuroleptics].
Topics: Animals; Catatonia; Caudate Nucleus; Cortical Spreading Depression; Dibenzazepines; Electroencephalo | 1971 |
Effect of thyroxine, pyridoxine, orphenadrine-HCl, resperine and disulfiram in periodic catatonia.
Topics: Basal Metabolism; Body Temperature; Body Weight; Catatonia; Catecholamines; Disulfiram; Humans; Inje | 1967 |
Effect of a striatal spreading depression on the pharmacogenic catatonia.
Topics: Animals; Catatonia; Caudate Nucleus; Cortical Spreading Depression; Dibenzoxazepines; Electroencepha | 1969 |